Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

FDA Committee Votes on Oral T1D Treatment Sotagliflozin

FDA Committee Votes on Oral T1D Treatment Sotagliflozin

By

The FDA takes the advice of the panel into consideration when making decisions, however it is not bound by their recommendations.

Health Experts Review 41 Diets, Rank Best Overall for 2019

Health Experts Review 41 Diets, Rank Best Overall for 2019

By

An expert panel assessed 41 diets to come up with their final results, examining the evidence behind each diet's claims, the short-term and long-term weight loss associated with the diet, how easy the diet is to follow, how well each diet conforms to current nutrition standards, and its effect on diabetes and cardiovascular disease prevention.

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

By

For this study, the authors identified randomized controlled trials (RCTs) that compared SGLT2 inhibitors with placebo, no treatment, or another antidiabetic agent and reported on UTI outcome.

Menopausal Hormone Therapy May Reduce Carpal Tunnel Syndrome Risk

Menopausal Hormone Therapy May Reduce Carpal Tunnel Syndrome Risk

By

To investigate the association between hormone therapy and carpal tunnel syndrome risk, researchers conducted a secondary analysis of the Women's Health Initiative (WHI) hormone therapy trials.

FDA to Review Estrogen-Free Oral Contraceptive Slinda

FDA to Review Estrogen-Free Oral Contraceptive Slinda

By

Drospirenone is a spironolactone analogue with antimineralocorticoid and antiandrogenic activity.

More Articles by Diana Ernst, RPh

Sign Up for Free e-Newsletters



CME Focus